Human Aortic Adventitial Fibroblasts (HAAF)

Overview

Human Aortic Adventitial Fibroblasts (HAAF) is a cell model used for research applications where physiologically relevant identity and donor background support interpretation of experimental readouts. Human Fibroblasts derived from aortic atery (Aortic Adventitial) within the Cardiovascular system.

In vascular adventitia, the outermost connective tissue covering the vessel, adventitial fibroblasts (AF) produce collagen to provide structural support by anchoring the blood vessel to nearby tissues. AF are the first cells of the vascular wall to respond to hypertension and vascular injury through activation and proliferation [1]. During pathological conditions, AF produce cytokines and chemokines to induce mass infiltration of immune cells into the adventitial layer of the vessel wall. Immune cell infiltration into the adventitia results in adventitial inflammation and can lead to cardiovascular disease [2, 3]. The important properties of AF make AF cultures an ideal tool for studying the pathogenesis of cardiovascular disease and for the development of novel disease treatments.They are also often used for the examination of fibroblast disorders like fibrosis or other diseases linked to either imperfect or excessive accumulation of fibroblasts. iXCells Biotechnologies provides high quality Human Aortic Adventitial Fibroblasts (HAAF), which are isolated from human aortic atery and cryopreserved at P1, with >0.5 million cells in each vial. HAAF are characterized by spindle morphology and express fibronectin. They are negative for HIV-1, HBV, HCV, mycoplasma, bacteria, yeast, and fungi and can further expand for 12 population doublings in Fibroblast Growth Medium(Cat# MD-0011) under the condition suggested by iXCells Biotechnologies.

Key elements and design rationale

• Cell identity: Fibroblasts (Primary Cells, Custom Cells)
• Source context: aortic atery; Aortic Adventitial; Cardiovascular
• Biosafety level: BSL-2 (follow your institution’s biosafety program and local regulations)

Product-specific elements (such as tissue source, donor background, and cell classification) help frame how results should be interpreted across assays and experimental conditions.

Biological background

Fibroblasts are key stromal cells that produce and remodel extracellular matrix, coordinate wound repair, and shape tissue microenvironments through paracrine signaling.

Across primary and specialty cell models, experimental outcomes can be influenced by donor heterogeneity, passage history, confluence, and media composition. For interpretation, it is common to validate key markers or functional phenotypes in the user’s assay context and to document culture variables consistently.

Research relevance and current trends

• Increasing use of primary and specialty cells to improve translational relevance for target biology and phenotypic screening.
• Adoption of 3D culture formats and co-culture systems to better capture tissue microenvironments and cell–cell interactions.
• Integration of functional readouts with single-cell and multi-omics profiling to connect phenotype with molecular state.
• Use of flow/shear and barrier-focused assays to study vascular inflammation, permeability, and angiogenic remodeling.

Common research applications

• Profile identity markers by flow cytometry or immunostaining in cultured cells
• Quantify functional responses to defined stimuli relevant to the model system
• Compare baseline phenotype across donors/conditions using gene expression profiling
• Evaluate angiogenic behavior using migration and tube-formation readouts (assay dependent)
• Screen compounds or genetic perturbations for phenotype modulation using viability or imaging endpoints

Interpretation typically focuses on how a perturbation (e.g., cytokine exposure, metabolic stress, genetic manipulation, or compound treatment) shifts marker profiles or functional readouts relative to an appropriate control matched for donor and culture variables.

Notes for experimental interpretation

• Donor-to-donor heterogeneity can influence baseline phenotype and treatment response; include biological replicates when feasible.
• Passage number, confluence, and media composition can shift gene expression and functional readouts; track and report these variables consistently.
• Contamination control (including routine mycoplasma monitoring) supports reproducibility in downstream assays.
• Use appropriate negative/positive controls for the readout (e.g., unstimulated controls, pathway agonists/antagonists) to contextualize observed changes.

SKU:BHC18500237

Customization & Add-ons: Can't find the cell line you need—or require a custom cell-based solution for your project? We can help you source the best match or support custom cell line services for diverse research needs, including cell line sourcing and selection (species, tissue, and disease model matching), stable cell line engineering (overexpression, knockdown, or knockout via CRISPR/Cas9, shRNA, or sgRNA), reporter gene integration (GFP, RFP, luciferase, and other fluorescent or bioluminescent constructs), genome editing and knockin (point mutations, tagged endogenous proteins, conditional alleles), inducible expression systems (Tet-On/Off and other regulatable constructs), drug resistance marker selection (puromycin, G418, hygromycin, and others), custom growth and media optimisation for specific assay requirements, scale-up production for high-throughput screening campaigns, and authentication and QC services (STR profiling, mycoplasma testing, viability assessment). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.